Stigma against weight loss drugs is driving some users to take them in secret.
Articles on Wegovy
Displaying 21 - 40 of 73 articles
Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher dose.
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
The development of new weight loss drugs is one way that patient access can be ensured in the future.
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
These annoying side-effects could potentially cause permanent damage to your teeth.
There are a number of reasons people are ‘microdosing’ weight-loss drugs. But here’s what to consider before you try it.
If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost down from around $500 a month to $31.60.
Resistance training is a key type of exercise to include when losing weight.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
Wegovy might be effective at treating everything from arthritis to alcohol addiction.
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.
There are many complex factors that contribute to weight gain and obesity.
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares with Ozempic.
The sellers of these online products acknowledge that many of their drugs are for ‘research purposes only’ or ‘not for human consumption.’
The weight loss drug is even more effective than Wegovy.
Patents for a drug related to Ozempic have expired, so pharmaceutical companies are working to develop ‘generic’ versions. These are likely to be much cheaper. But how do they compare with Ozempic?
Top contributors
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
General Practitioner, PhD Candidate, Bond University
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Clinical Epidemiologist, Washington University in St. Louis
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Senior Lecturer, Pharmacy, Aston University
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Associate Professor of Nutrition, University of Surrey
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor of Gastroenterology, School of Medicine, University of Washington
-
Honorary Associate Professor, University of Leicester